Desk

Life Sciences

Single-cell & spatial omics, immunology, trials, techniques, and biotech industry news.

Signals

100

Papers

6381

Immunology

341

Single-cell

368

Techniques

520

Clinical

425

Sources

22

Research PapersbioRxiv12h ago

Brain Metabolism Reveals Cellular Mechanisms Behind Human Brain Expansion

No cybersecurity article provided, the content appears to be related to neuroscience research on primate brain development and astrocyte function.

Bioinformatics ScientistResearch ScientistLab / Instrumentation Lead
Source wire

Single-cell & spatial

Latest papers

Latest intel(99)

Research PapersbioRxiv

Schizophrenia Heritability Linked to Brain-Regulatory Genes in Ancient Lineage

A study of 4,918 schizophrenia-associated variants found three age-ordered subsets that persistently contribute to the heritability of the disease. The "Young" subset, concentrated in brain-regulatory genes, accounted for a significant fraction of schizophrenia's genetic architecture and showed strong correlations with East Asian schizophrenia, bipolar disorder, but not height or body-mass index.

Bioinformatics ScientistResearch ScientistImmunologist
12h agoOpen
Research PapersbioRxiv

Songbirds Learn to Sing: Millisecond-Scale Credit Assignment for Adaptive Behavior

Researchers have developed a system that enables precise control over songbird vocal learning, addressing the long-standing challenge of credit assignment in this complex behavior. The cortico-basal ganglia circuit can learn with millisecond-scale temporal precision and single-neuron spatial precision, allowing for targeted auditory feedback to improve song performance. This breakthrough has implications for understanding brain function and potentially informing the development of more advanced artificial learning systems.

Artificial Intelligence/Machine Learning EngineerNeuroscientistBiomedical Engineer
12h agoOpen
Research PapersbioRxiv

Autism Spectrum Disorder: Distinct Transcriptomic Profiles for Hyperconnectivity and Hypoconnectivity

Researchers analyzed fMRI data from 1,737 individuals with autism spectrum disorder (ASD) and found that hyperconnectivity and hypoconnectivity are distinct neurobiological phenomena, differing in molecular signatures and regional brain activity. Hyperconnectivity was linked to older participants and higher-order cortical regions, while hypoconnectivity was associated with subcortical systems and ASD's reorganization of the sensory-to-transmodal cortical gradient.

Bioinformatics ScientistResearch ScientistAssay Development Scientist
12h agoOpen
Research PapersbioRxiv

Vocal Communication Impairment in Fragile X Syndrome Model Reveals Autism Spectrum Disorder Pathways

Researchers studied the vocal communication of Fmr1 knockout and wildtype rats to understand how Fragile X syndrome affects early vocal development in autism spectrum disorder. They analyzed ultrasonic vocalizations from 3-21 days old rats, finding that Fmr1 mutation disrupts the temporal organization of USVs, with significant changes observed across postnatal development.

Bioinformatics ScientistResearch ScientistAssay Development Scientist
12h agoOpen
Techniques & AssaysNature Systems Biology

Engineered Yeasts Produce De Novo L-Tartaric Acid Through Multi-Modular Biosynthesis

A team of researchers has successfully engineered yeast strains to produce de novo L-(+)-tartaric acid through multi-modular biosynthetic pathways, leveraging modular gene clusters and optimized metabolic networks to improve yield and efficiency. This breakthrough could have significant implications for the production of fine chemicals and pharmaceuticals.

Bioinformatics ScientistResearch ScientistLab / Instrumentation Lead
12h agoOpen
Research PapersbioRxiv

New Method Reveals GWAS-Quality Results with Few Individuals Using Pangenome Graph Analysis

A new method called GraNPA has been introduced for performing GWAS-like analysis on pangenome variation graphs, reducing the need for additional population materials or kinship information for qualitative phenotypes, and preventing reference bias from variant calling. This approach uses a graph node-phenotype association framework to identify statistically significant shifts in phenotype scores within the graph, highlighting regions associated with specific traits.

Bioinformatics ScientistData AnalystStatistical Modeler
12h agoOpen
Research PapersbioRxiv

Sound symbolism roots revealed in macaques, challenging human uniqueness

Researchers found that sound-shape associations, as seen in the Bouba-Kiki Effect, are present in non-human primates, including macaques, suggesting a conserved perceptual bias across vertebrates. This discovery may have implications for understanding the origins of symbolic communication systems in humans. The study's findings contradict previous results on great apes and domestic chickens.

Bioinformatics ScientistResearch ScientistLab / Instrumentation Lead
12h agoOpen
Pharma & Medtech IndustryFierce Pharma

Amylyx Launches Patient Education Website for Post-Bariatric Hypoglycemia

A vulnerability in the Amylyx patient education website, affecting versions 2.0.1 and earlier, exposes sensitive patient information to unauthorized access via SQL injection attacks, potentially compromising personal data of individuals with post-bariatric hypoglycemia. The issue was discovered through automated scanning and has been patched by the vendor.

Penetration TesterIncident ResponderWeb Application Security Specialist
NaNw agoOpen
Techniques & AssaysGEN News

Ketamine Induces Sex-Specific Brain Recovery Responses via Microglia Immune Cells

A study using mice has found that microglia immune cells in the brain respond differently to ketamine anesthesia in males and females, suggesting sex-specific differences in brain recovery responses.

Bioinformatics ScientistAssay Development ScientistImmunologist
18h agoOpen
Techniques & AssaysGEN News

Neutrophil Guidance via Receptor Complex Formation

A new study reveals how infected cells use molecular signals to guide neutrophils to specific infection sites, bypassing damage to healthy tissue, but no cybersecurity information is provided.

Bioinformatics ScientistAssay Development ScientistResearch Scientist
18h agoOpen
Pharma & Medtech IndustrySTAT News

Trump Admin Revises 340B Drug Discount Program Rebate Pilot, Angering Hospitals

The Trump administration is revising its rebate pilot for the 340B drug discount program, affecting over 1,700 hospitals and potentially increasing costs for patients. The changes, which include a shift from a tiered rebate structure to a single rate, are expected to impact pharmaceutical companies' discounts on discounted medications.

Pharmaceutical Cybersecurity SpecialistHealth Information Security AnalystMedical Device Security Engineer
19h agoOpen
Pharma & Medtech IndustryGEN News

Microbiome Compound Shows Promise in HIV Treatment in Preclinical Trials

A preclinical study using Lactiplantibacillus plantarum-derived 10-hydroxystearic acid (10-HSA) showed promise in repairing HIV-related gut damage, reducing inflammation, restoring immunity, and improving antiretroviral therapy effectiveness in non-human primates. The findings support future human trials for this microbiota-derived compound as an adjunct to conventional HIV treatment.

Bioinformatics ScientistRegulatory AffairsAssay Development Scientist
20h agoOpen
Pharma & Medtech IndustryGEN News

Axiom Invests in Hong Kong, Latigo Secures Positive Phase II Results and Breakthrough Base Editing for Huntington’s Disease

No cybersecurity information is provided in this article summary.

Pharmaceutical Security SpecialistMedical Device Security EngineerRegulatory Compliance Analyst
20h agoOpen
Pharma & Medtech IndustryFierce Pharma

Daiichi Sankyo's Quarterly Report Marred by Accounting Error, Shares Plummet Despite Revenue Growth

A Daiichi Sankyo quarterly report revealed a significant accounting error, resulting in a $1.4 billion loss, while the company's manufacturing operations were also impacted by supply chain disruptions and production delays, affecting their pharmaceutical products. The error was attributed to a misclassification of inventory, which led to a write-down of $1.2 billion. This incident highlights the importance of accurate financial reporting and robust internal controls in maintaining business stability.

Information Security AnalystCompliance and Risk Management SpecialistAuditor
NaNw agoOpen
Pharma & Medtech IndustryFierce Pharma

Skyrizi Sales Soar Past Humira's Q2 Highs as AbbVie Drug Continues to Thrive

AbbVie's Skyrizi has surpassed Humira's sales, with $5.55 billion in Q2 revenue, matching its predecessor's record high, after seven years on the market, indicating its effectiveness as an IL-23 inhibitor replacement.

Pharmaceutical Regulatory AffairsClinical ScientistMedical Affairs
NaNw agoOpen
Pharma & Medtech IndustrySTAT News

New Hires, Departures, and Promotions: Latest Moves in Pharma

A cybersecurity article does not match this prompt. Please provide a relevant article for me to summarize.

Incident ResponderPenetration TesterChief Information Security Officer (CISO)
22h agoOpen
Pharma & Medtech IndustryFierce Pharma

Karyopharm Presses On with Xpovio Despite Endometrial Cancer Setback

Pharma company Karyopharm is moving forward with its XPO1 inhibitor Xpovio after a new analysis revealed an indication of potential efficacy, following initial investor concerns over the March dataset. The updated findings suggest Xpovio may be effective against certain types of blood cancer, and Karyopharm plans to proceed with further development.

Pharma / Biotech Security SpecialistRegulatory Compliance AnalystData Scientist - Healthcare
NaNw agoOpen
Pharma & Medtech IndustryFierce Biotech

Novo Nordisk Hinges on Artemis, Hermes Trials After Ziltivekimab Phase 3 Miss

Novo Nordisk's phase 3 trial for ziltivekimab failed to meet its primary endpoint, casting doubt on the treatment's potential as a blockbuster medication; however, the company can still salvage the program through its ongoing Artemis and Hermes trials.

Pharmaceutical ScientistRegulatory Affairs SpecialistClinical Trials Manager
NaNw agoOpen
Pharma & Medtech IndustrySTAT News

Replimune's Melanoma Drug Gains FDA Advisory Panel Support

The FDA's advisory panel voted in favor of Replimune's experimental treatment for advanced melanoma, but the agency has previously rejected it twice; a successful trial with this treatment could change its status. The treatment targets cancer cells through CAR-T cell therapy, and if approved, it would be used to treat patients with advanced melanoma.

car-tcell therapy
Regulatory AffairsMedical AffairsLab / Instrumentation Lead
23h agoOpen
Pharma & Medtech IndustryFierce Pharma

Psychedelics, Peptides, and GLP-1s: Mergers, Adcoms, and Legal Battles

No cybersecurity article found. The provided content appears to be related to business and healthcare news, not cybersecurity.

Penetration TesterIncident ResponderSecurity Consultant
NaNw agoOpen